Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

62.42

+2.01 (3.33%)

At close: Mar 9, 2026, 4:00 PM EDT

61.00

-1.42 (-2.27%)

After-hours: Mar 9, 2026, 4:17 PM EDT

Cytokinetics Market Cap

Cytokinetics has a market cap or net worth of $7.69 billion as of March 9, 2026. Its market cap has increased by 27.43% in one year.

Market Cap

7.69B

Enterprise Value

8.16B

1-Year Change

27.43%

Ranking

#1080

Market Cap Chart

Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $7.69B, an increase of 1,733.49%. That is a compound annual growth rate of 14.23%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	7.44B	-4.23%
Dec 31, 2025	7.77B	39.94%
Dec 31, 2024	5.55B	-32.19%
Dec 29, 2023	8.19B	88.80%
Dec 30, 2022	4.34B	13.41%
Dec 31, 2021	3.82B	159.95%
Dec 31, 2020	1.47B	134.61%
Dec 31, 2019	626.90M	81.29%
Dec 31, 2018	345.80M	-21.27%
Dec 29, 2017	439.20M	-10.79%
Dec 30, 2016	492.30M	21.17%
Dec 31, 2015	406.30M	38.57%
Dec 31, 2014	293.20M	52.87%
Dec 31, 2013	191.80M	104.04%
Dec 31, 2012	94.00M	35.45%
Dec 30, 2011	69.40M	-49.60%
Dec 31, 2010	137.70M	-22.34%
Dec 31, 2009	177.30M	25.83%
Dec 31, 2008	140.90M	-39.40%
Dec 31, 2007	232.50M	-17.84%
Dec 29, 2006	283.00M	51.01%
Dec 30, 2005	187.40M	-35.49%
Dec 31, 2004	290.50M	-30.72%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ABIVAX Société Anonyme	8.49B
Vaxcyte	8.47B
Bio-Techne	8.44B
Axsome Therapeutics	8.33B
Arrowhead Pharmaceuticals	8.32B
Halozyme Therapeutics	7.94B
Nuvalent	7.77B
Krystal Biotech	7.45B

Market Cap Rankings